Company Filing History:
Years Active: 2009-2013
Title: David George Hubert Livermore: Innovator in Medical Chemistry
Introduction
David George Hubert Livermore is a notable inventor based in Harlow, United Kingdom. With a total of four patents to his name, his work primarily focuses on advancements in medical chemistry, specifically the action of oxytocin in treating various conditions.
Latest Patents
Among Livermore's most significant contributions are his recent patents concerning substituted diketopiperazines as oxytocin antagonists. These innovative methods aim to treat or prevent diseases mediated through oxytocin activity. His research establishes the efficacy of administering specific compounds or their pharmaceutically acceptable salts to individuals in need, marking a promising direction in therapeutic approaches.
Career Highlights
David Livermore has held positions at prominent companies, including Glaxo Group Limited and SmithKline Beecham Corporation, where he has contributed to groundbreaking research and development in the pharmaceutical industry. His expertise in compound formulation and application showcases his skill and dedication to innovation in healthcare.
Collaborations
Throughout his career, Livermore has had the opportunity to collaborate with esteemed colleagues, including Alan D Borthwick and Richard Jonathan Hatley. These partnerships highlight the collaborative spirit prevalent in the field of scientific research, driving forward the quest for new solutions in medicine.
Conclusion
David George Hubert Livermore's work exemplifies the impactful nature of innovation in the pharmaceutical industry. With his expertise and inventive spirit, he continues to contribute to advancements that have the potential to improve healthcare and patient outcomes. His patents represent significant strides in understanding and manipulating oxytocin, advancing the treatment of related diseases.